Anika Therapeutics Inc.
ANIK
Market Cap$212.97M
Close$
$2.78
76.2% downside
Current Fair Value
76.2% downsideOvervalued by 76.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $212.97 Million |
|---|---|
| Enterprise Value | $183.34 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3.83 |
| Beta | 0.81 |
| Outstanding Shares | 14,576,666 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.84 |
|---|---|
| PEG | -1.08 |
| Price to Sales | 1.06 |
| Price to Book Ratio | 1.16 |
| Enterprise Value to Revenue | 1.12 |
| Enterprise Value to EBIT | -5.38 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.17 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Anika Therapeutics Inc.
CEO: Joseph Darling